ArticleCancers2022

18FDG PET Assessment of Therapeutic Response in Patients with Advanced or Metastatic Melanoma Treated with First-Line Immune Checkpoint Inhibitors.

Alexia Rivas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.